Showing 981 - 1,000 results of 17,627 for search '"The Progressive"', query time: 0.07s Refine Results
  1. 981

    Inference of Process Capability Index Cpy for 3-Burr-XII Distribution Based on Progressive Type-II Censoring by Rashad M. EL-Sagheer, Mustafa M. Hasaballah

    Published 2020-01-01
    “…In this paper, we discussed the estimation of the index Cpy for a 3-Burr-XII distribution based on Progressive Type-II censoring. The maximum likelihood and Bayes method have been used to obtain the estimating of the index Cpy. …”
    Get full text
    Article
  2. 982

    Research Progress of Transcranial Direct Current Stimulation Therapy for Cognitive Impairment after Stroke by LIU Yuanchen, ZHANG Lixin

    Published 2024-06-01
    “…This article aims to review the research progress of tDCS and other cognitive rehabilitation methods in PSCI, so as to provide therapeutic experience and reference for the comprehensive rehabilitation of PSCI.…”
    Get full text
    Article
  3. 983
  4. 984
  5. 985
  6. 986

    Deconstruction of “The Pilgrim’s Progress” by John Bunyan in Kurt Vonnegut’s “Slaughterhouse-Five, or The Children’s Crusade” by Nataliya Krynytska

    Published 2024-12-01
    “…He creates an alternative to the pilgrim’s progress in Bunyan’s novel, since the linearity of the development of civilization and Protestant ethics lead to catastrophes like World War II. …”
    Get full text
    Article
  7. 987

    Nootkatone inhibits the progression of glioblastoma by activating the ATF4-CHOP-CHAC1 pathway by Qian Wang, Xiumin Xue, Zhichao Chen, Wei Zhang, Yiming Qian, Danni Chen, Lin Lin, Yinfeng Yuan, Weiqiao Zhao, Zhihui Huang, Yongjie Wang

    Published 2025-01-01
    “…Mechanistically, we found that NKT inhibited the progression of GBM cells through activating the ATF4-CHOP-CHAC1 pathway in GBM cells. …”
    Get full text
    Article
  8. 988
  9. 989

    Tumor-associated macrophages contribute to cholangiocarcinoma progression and chemoresistance through activation of ID1 by Yinghao Guo, Shuangda Miao, Yun Jin, Qi Li, Yihang Wang, Xiaoxiao Zhang, Jiangtao Li

    Published 2025-01-01
    “…Conclusions: TAM promotes CCA progression and chemoresistance through activating OSM-Yap-ID1.…”
    Get full text
    Article
  10. 990
  11. 991

    Research Progress of Fuzheng Jiedu Huayu Method in Reducing Toxicity and Enhancing Efficacy of Immunotherapy by Yufan CHEN, Sicong LI, Yiyuan CUI, Li FENG

    Published 2025-01-01
    “…This article summarizes the research progress of immunotherapy and discusses how TCM reduces the toxicity and enhances the efficacy of immunotherapy, hoping to provide a reference for the integrated treatment of tumors with TCM and immunotherapy.…”
    Get full text
    Article
  12. 992

    Altering the redox status of Chlamydia trachomatis directly impacts its developmental cycle progression by Vandana Singh, Scot P Ouellette

    Published 2025-01-01
    “…Together, these results indicate that redox potential is a critical factor in developmental cycle progression. For the first time, our study provides a mechanism of chlamydial secondary differentiation dependent on redox status.…”
    Get full text
    Article
  13. 993
  14. 994
  15. 995

    Investigating the role of intratumoral Streptococcus mitis in gastric cancer progression: insights into tumor microenvironment by Ping Yang, Gaoli Liang, Yangyue Ni, Xiaojie Chu, Xiaoshan Zhang, Zhongyu Wang, Adeel Khan, Fangfang Jin, Han Shen, Miao Li, Zhipeng Xu

    Published 2025-01-01
    “…Abstract Growing evidence implicates that intratumoral microbiota are closely linked to cancer progression; however, research on the role of these microbiota in the development of gastric cancer remains limited. …”
    Get full text
    Article
  16. 996

    Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm by Charlotte Pawlyn, Fredrik H. Schjesvold, David A. Cairns, L. J. Wei, Faith Davies, Omar Nadeem, Haifaa Abdulhaq, Maria-Victoria Mateos, Jacob Laubach, Katja Weisel, Heinz Ludwig, S. Vincent Rajkumar, Pieter Sonneveld, Graham Jackson, Gareth Morgan, Paul G. Richardson

    Published 2024-08-01
    “…Surrogate endpoints of OS, such as progression-free survival (PFS) and response to treatment, have contributed to approval decisions by the Food and Drug Administration (FDA) and European Medicines Agency as endpoints demonstrating clinical benefit, and the FDA has recently supported the use of minimal residual disease (MRD) as an accelerated approval endpoint in multiple myeloma. …”
    Get full text
    Article
  17. 997

    NIPAL1 as a prognostic biomarker associated with pancreatic adenocarcinoma progression and immune infiltration by Youlong Zhu, Zongze Qi, Shaoqi Zu, Fangchao Yang, Yanming Wang, Lei Zhu, Xintong Li, Ruixue Li, Hong Zhu

    Published 2025-01-01
    “…Recent genetic studies have revealed that the abnormal expression and functional dysregulation of various genes are involved in the occurrence and progression of pancreatic cancer. NIPA-like proteins (NIPAs) are expressed in a variety of cancer types, yet the role of NIPAL1 in cancer remains unclear. …”
    Get full text
    Article
  18. 998
  19. 999

    Application Progress of Transcranial Direct Current Stimulation in Rehabilitation of Chronic Low Back Pain by SHI Jian, WAN Ruihan, WANG Yafei, GONG Chen, WANG Yuling

    Published 2023-10-01
    “…This article reviews the current domestic and international research progress of tDCS in CLBP rehabilitation in recent years and discusses the factors that affect its curative effect (e.g., stimulation target, frequency, and synergistic treatment scheme) and possibly effective treatment modes. …”
    Get full text
    Article
  20. 1000